• SHL Telemedicine first-half revenue rose 12.19% to USD 31.32 million, with net loss narrowing 9.38% to USD 3.94 million.
• Operating loss narrowed 20.6% to USD 2.78 million, while consolidated adjusted EBITDA doubled to about USD 1.8 million.
• Management attributed revenue growth mainly to foreign-exchange movements, citing continued operating cost reductions and higher new-subscriber recruiting rates.
• Israel remained stable with improved B2B performance, while Germany revenue kept declining on tender expirations and the company continued rightsizing costs.
• U.S. efforts stayed focused on building distribution; the subscriber base increased in the first half, supporting management’s growth expectations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SHL Telemedicine Ltd. published the original content used to generate this news brief on September 09, 2026, and is solely responsible for the information contained therein.